THE PROBLEMS AND PROGNOSIS OF THE CHRONICALLY SURVIVING PATIENT AFTER RENAL HOMOTRANSPLANTATION by Starzl, TE et al.
THE PROBLEMS AND PROGNOSIS O F  THE 
CHRONICALLY SURVIVING PATIENT AFTER 
RENAL HOMOTRANSPLANTATLON 
T. E. Starzl, T. L. Marchiom, T. D. Faris, M. P. Hutt, 
T. A. Carey, S. A. 0 gden, W. R. Waddell and K. A. Porter 
R e p r i n t e d  from 
A N N A L S  OF T H E  NEW YORK ACADEMY O F  S C I E N C E S  
Volume 129. A r t i c l e  1, Pages 598-614 
December  30, 1966 
T H E  PROBLEMS AND PROGNOSIS OF T H E  
CHRONICALLY SURVIVING PATIENT AFTER 
RENAL HOMOTRANSPLANTATION* 
T.  E. Starzl, T.  L. Marchioro, T. D. Faris, M. P. Hutt ,  
T. A. Carey, D. A. Ogden, W. R. Waddell 
Departments of Surgery and Medicine, University of Colorado 
School of Medicine, the Denver Veterans Administration Hospital 
and 
K .  A. Porter 
Department of Pathology, St. Mary k Hospital and 
Medical School, London, England 
On previous occasions, reports have been published on a consecutive group 
of 64 patients treated a t  the University of Colorado Medical Center with 
renal homografts obtained from living volunteer donors.'" In the last of these 
communications,2 prepared in May of 1965, the mortality was summarized. 
Late complications, homograft function, the results of retrospective antigen 
analysis (performed by Paul Terasaki), and pathologic studies were docu- 
mented in detail. In addition, the possible role of thymectomy in promoting 
homograft acceptance was discussed. 
The following is a further brief report on the same patients. In the inter- 
vening nine months two additional deaths have occurred, leaving a residua of 
34 chronic survivors who are now from 22i to 39 months posttransplant. 
The therapy provided and detailed accounts of each of the 64 cases have 
been described."' 
Mortality. Twenty-seven of the 30 deaths occurred during the first post- 
operative year (TABLE 1). Twenty-three patients died within 120 days of 
operation. Four more succumbed between the fourth and tenth months. One 
2 patient, previously reported, died 13: months after transplantation from 
hepatitis and septicemia. Since May of 1965, two additional late deaths have 
occurred. 
Case 1 (LD36). A 43-year-old man was first seen a t  the University of 
Colorado Medical Center on September 18, 1963. At age two, he had a "strep 
*Aided by Grants AM 06283, AM 06344, HE 07735, AM 07772, A1 04152, FR 00051 
and FR 00069 from the United States Public Health Service and by a grant from the 
Medical Research Council of Great Britain. 
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3-36-39 months 
1-22 months 17-24-30 months 
*None of the surviving patients has had late retransplantation. 
TABLE 1 
SURVIVAL STATISTICS IN 64 CONSECUTIVE PATIENTS TREATED 
WITH RENAL HOMOGRAFTS FROM NOVEMBER, 1962 TO MARCH, 1964 
throat which settled in his kidneys." At age 21, he was rejected for military 
service because of proteinuria. Hypertension was first noted when he was 37. 
I n  November of 1962 his BUN had been 26 mg%, but  in January of 1963 
he first had uremic symptoms, including vomiting. A right retrograde pyelo- 
Total No. 
Patients 
FIGURE 1. Own left kidney from Case 1 (LD36). On the right of the photomicrograph 
there is a chronic pyelonephritic scar in which the glomeruli are fibrosed, the tubules 
atrophic, and the interstitiurn densely infiltrated with lymphocytes. Relatively normal 
renal tissue is present on the left. H & E x 80. 
- 
Deaths Within 
First  Year 
Deaths After 
First  Year 
Survivors * 
at 2/16/66 
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gram at that time showed a normal calyceal system. At the time of his first 
admission to Colorado General Hospital BUN was 94 mg%, plasma creatinine 
was 15.2 mg% and his daily urine (average volume 1200 ml) contained 2.6 to 
6.1 gm protein. Urine cultures were sterile. Conservative management was 
elected, but five days after discharge he was readmitted with vomiting, and an 
increase of BUN and creatinine to 125 mg% and 18.3 mg%, respectively. Dur- 
ing the next ten days the BUN rose to 170 mg%. After hemodialysis he received 
bilateral nephrectomy, splenectomy, and renal homotransplantation on Octo- 
ber 14, 1963. The homograft was donated by his wife; the blood groups were 
Of to Bf. Ischemia was 38 minutes. His own diseased kidneys were shrunken 
and coarsely scarred. Microscopically, the fibrosed areas were densely infil- 
trated by lymphocytes and showed glomerular destruction and tubular atro- 
phy; elsewhere, there were a few hypertrophied glomeruli and hyperplastic 
tubules (FIGURE 1). These appearances were suggestive of chronic pyelone- 
nephritis rather than glomerulonephritis. 
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FIGURE 2. Course of a 43-year-old patient (LD36) who died 711 days after renal 
homotransplantation. His wife was the donor; blood group transfer was Of to Bf. Note 
the jaundice which was first observed five months after operation and which recurred 
intermittently until the time of death. The reduction in immunosuppression which was 
instituted because of the hepatic complications may have been responsible for the late 
homograft failure. Note also the temporary further impairment of renal function during a 
course of ethacrynic acid. 
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FIGURE 3. Biovsv of renal homograft from Case 1 (LD36) one vear, ten months after 
transplantation. The glomerular capillary basement membranes are diffusely thickened. 
PAS x 400. 
Rejection was diagnosed one day postoperatively and treated with the ad- 
dition of 200 mg prednisone per day to the preexisting azathioprine therapy 
(FIGURE 2). Recovery was rapid thereafter. He was discharged from the hos- 
pital on November 20,1963 with 60 mg/day prednisone, and 250 mglday aza- 
thioprine; his BUN was 23 mg% and creatinine clearance was 85 mllmin. 
During the ensuing four months prednisone was lowered to 15 mglday and 
azathioprine to 225 mglday without change in renal function. 
He was re-admitted to the hospital on March 18, May 1 and September 16 
for "hepatitis." On each occasion he was jaundiced (FIGURE 2), had eleva- 
tions in SGOT, SGPT, alkaline phosphatase and BSP retention, as well as 
depressions in serum protein. Because of the liver injury, the daily azathio- 
prine dose was reduced to 125 mglday. His condition remained stable until the 
last two weeks of May of 1965 when he developed massive proteinuria (as 
much as 35 gmlday); serum albumin was 2.3 gm%. His BUN rose to 45 mg% 
and creatinine clearance fell to 50 ml/min. Although he was not jaundiced, 
BSP retention was 31% and prothrombin time 50%. The subsequent azathio- 
prine doses were 0-150 mglday. Prednisone was increased from 12.5 to 45- 
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FIGURE 4. Biopsy of renal homograft from Case 1 (LD36). The juxtaglomerular 
apparatus, indicated by an arrow, is greatly enlarged. PAS x 400. 
100 mg/day. I n  addition, two courses of local homograft irradiation were 
given in early June and late August (450R each time in three divided doses). 
The proteinuria decreased to 2-6 gm/day, but the BUN and creatinine clear- 
ance were not improved. A course of ethacrynic acid therapy (FIGURE 2) 
resulted in temporary further deterioration in renal function. After this, the 
BUN and creatinine clearance ranged 30-150 mg% and 10-40 ml/min respec- 
tively until two days before his death. Liver functions worsened with return 
of hyperbilirubinemia (maximum 7 mg%), and depression of total protein to 
3.7 gm% with 1.3 gm% albumin; gamma globulin was normal (0.8 to 1.3 
gm%). Open renal and liver biopsies were carried out on August 27. 
The renal biopsy showed diffuse thickening of all the glomerular capillary 
walls and increase in the mesangial matrix caused by deposits of homogeneous 
material which stained positively with periodic-acid Schiff (PAS) reagent 
(FIGURE 3). The glomerular changes closely resembled those seen in diffuse 
membranous glomerulonephritis. The juxtaglomerular bodies were enlarged 
by hyperplasia both of the cells in the arteriolar walls and of the lacis cells, 
but the number of PAS-positive granules was not increased (FIGURE 4). The 
macula densa was prominent. Scattered areas of tubular atrophy and intersti- 
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tial fibrosis were present throughout the specimen but were particularly com- 
mon just beneath the capsule. There were also several foci of infiltrating 
mononuclear cells, usually adjacent to small veins. About 40 percent of these 
cells were lymphoid and possessed cytoplasm which stained positively with 
methyl-green pyronin; similar cells were found in the peritubular capillaries. 
Large subendothelial deposits of homogeneous hyaline material were present 
in the walls of afferent and efferent arterioles. Many of the interlobular 
arteries were greatly narrowed or obstructed by fibrous thickening of the in- 
tima (FIGURE 5), a change sometimes accompanied by reduplication of the 
internal elastic lamina. 
The liver biopsy showed condensation of reticulin and deposition of fibrous 
tissue around the central veins, together with portal fibrosis. Bands of con- 
nective tissue linked portal tracts one to the other (FIGURE 6). There was a 
moderately dense portal infiltration with mononuclear cells, most of which 
were lymphocytes and plasma cells. The centrilobular Kupffer cells contained 
hemosiderin and there were many fine fat droplets in the cytoplasm of the 
majority of the hepatocytes. There was no cholestasis. 
On September 23, 1965, he developed Staphylococcus aureus cellulitis 
FIGURE 5. Biopsy of renal homograft from Case 1 (LD36). An arcuate artery is 
greatly narrowed by fibrous thickening of the intima. Weigert's elastic x 150. 
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FIGURE 6. Liver biopsy from Case 1 (LD36). The lobular reticulin framework is 
collapsed and condensed around the central vein (cv) and there is portal fibrosis (P). 
Connective tissue bands link portal tracts. Reticulin stain x 80. 
around a small ulcer on his sacrum. Despite specific antibiotic therapy, this 
spread within hours to involve the entire trunk and thorax, leading to death 
on September 25. Posttransplant survival was 711 days. 
At autopsy, it was found that changes similar to those seen in the biopsy 
were present elsewhere in the renal transplant. The band of scarring immedi- 
ately beneath the renal capsule was particularly prominent. Fibrous intimal 
thickening extended to the arcuate and interlobar arteries. Several of these 
larger vessels were completely obstructed. The anastomoses of the renal artery 
and vein to the iliac vessels were not stenosed. The hepatic findings were also 
confirmed a t  autopsy. In addition, widespread cytomegalic inclusion disease 
was found, particularly affecting the lungs and the adrenals. There was mas- 
sive cellulitis of the skin and subcutaneous tissues with necrosis and edema, 
large collections of bacteria, and no evidence of a cellular reaction to the 
infection. 
Case 2 (LD47). A 39-year-old man was admitted to Colorado General Hos- 
pital in November of 1963 with hypertension, azotemia, and congestive heart 
failure. His BUN was 150-200 mg% and plasma creatinine was 20 mg%. He 
was treated with multiple hemodialyses. After eight days of pretreatment 
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with azathioprine and two days of 200 mg/day prednisone, he received splenec- 
tomy, bilateral nephrectomy and renal transplantation on January 4, 1964. 
Both the patient and his fraternal donor were Af blood type; ischemia time 
was 28 minutes. His own kidneys were almost completely destroyed by chronic 
~ l l i s ~  type 1 glomerulonephritis. 
After excellent initial function, he had a rejection crisis on the 14th day. 
This was treated with local homograft irradiation (450 R). His subsequent 
course was uneventful and he was discharged from the hospital after six weeks 
with a BUN of 26 mg% and a Ccr of 86 ml/min (FIGURE 7). During the 
ensuing eight months, his prednisone dose was reduced to 10 mglday. Two 
hundred and seventy days after operation he had a sudden late rejection which 
resulted in elevation of BUN to 80 mg% and a decrease in Ccr to 50 mllmin. 
Proteinuria of 1.5 to 7.0 gm/day persisted thereafter. He was treated with 
local homograft irradiation (450 R), actinomycin C and an increase in steroid 
dose to 100 mglday. During the remaining 15 months of his life his renal func- 
tion never again approached that which existed before the late rejection. On 
October 27, 1964, thymectomy was performed without demonstrable subse- 
quent benefit. His BUN thereafter ranged from 50 to 85 mg% and the Ccr was 
20-50 ml/min. until a few days before death. 
Despite maintenance of reduced, though life-sustaining homograft func- 
tion, his general condition deteriorated, requiring several hospitalizations for 
diffuse bone and abdominal pain. Since these were thought to be steroid com- 
plications, his prednisone dose was gradually reduced to 40 mglday. 
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FIGURE 7. Course of a 37-year-old man (LD47) who received a kidney from his 
younger brother. Both were Af blood type. Note the severe late rejection after nine 
months and the subsequent slow deterioration of renal function. The late thymectomy 
did not induce either lymphopenia or make the subsequent management easier; the post- 
thymectomy changes in lymphocyte counts were related to adjustments in steroid dosage.2 
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FIGURE 8. Renal homograft from Case 2 (LD47) at  autopsy one year ten months after 
transplantation. Fat emboli, which appear black in the photomicrograph, are present in 
the glomerular tuft capillaries and in the afferent and efferent arterioles. Frozen section 
stained with oil red 0 x 400. 
In August of 1965 a diffuse pulmonary infiltrate was noted by x-ray. Tra- 
cheal aspirate demonstrated Pneumocystis carinii which was treated with 
pyrimethamine and sulfadiazine. He became progressively hypoproteinemic, 
ultimately reaching a low of 4.lgm% total plasma protein with albumin of 
1.5 gm%. His gamma globulins were not depressed. Numerous amylase deter- 
minations during the last two months of his life were elevated and progres- 
sive rises were observed in alkaline phosphatase (maximum 30.5 Bessey- 
Lowry units). He did not become jaundiced. He had a consistent fever during 
this time. 
Terminally, renal function deteriorated markedly with Ccr's of 3-10 ml/ 
min (FIGURE 7). Five days before his death, a kidney obtained from a cadav- 
eric donor of the same blood type was transplanted to the retroperitoneal 
space of the opposite side. There was no evidence of function from the second 
homograft. The patient died five days later on October 31, 1965. His total 
survival was 665 days. 
At autopsy, there was a great deal of scarring in the superficial cortex of 
the first renal homograft. Foci of interstitial fibrosis and tubular atrophy were 
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also distributed throughout the kidney. A few of these scars were infiltrated by 
mononuclear cells most of which were small lymphocytes, although about 5 
percent were larger lymphoid cells with pyroninophilic cytoplasm. Fat  emboli 
were present in the tuft capillaries of many glomeruli (FIGURE 8). In addition, 
several of the glomeruli showed focal thickening of the capillary basement 
membranes by PAS-positive material (FIGURE 9). A similar substance was 
deposited in the mesangium. There was moderate hyperplasia of all elements 
of the juxtaglomerular bodies. Many of the interlobular, arcuate and inter- 
lobar arteries were greatly narrowed by fibrous thickening of the intima (FIG- 
URE lo) ,  associated in several vessels with rupture of the internal elastic 
lamina. The arterioles, peritubular capillaries and veins were normal. The 
second renal homograft showed only acute tubular necrosis in the process of 
healing. 
There was severe fatty infiltration of the liver, all the hepatocytes being 
heavily laden with large droplets of fat (FIGURE 11). The Kupffer cells con- 
tained a great deal of hemosiderin and there was some centrilobular cholestasis 
with bile "thrombi." Cytomegalic inclusion disease was found particularly af- 
FIGURE 9. Renal homograft from Case 2 (LD47). There is hyperplasia of the juxta- 
glomerular apparatus, which is indicated by an arrow, and focal thickening of the glo- 
merular capillary basement membranes. PAS x 400. 
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FIGURE 10. Renal homograft from Case 2 (LD47). An arcuate artery is almost obli- 
terated by eccentric fibrous intimal thickening. Around the vessel there is tubular atro- 
phy and interstitial fibrosis but very little cellular infiltration. Weigert's elastic x 150. 
fecting the lungs and liver. The consolidated lungs were also diffusely infected 
by Pneumocystis carinii and contained necrotic foci filled with colonies of 
Aspergillus fumigatum. Fat emboli were present in many of the alveolar capil- 
laries. There was pancreatitis accompanied by surrounding fat necrosis. 
Survival. Thirty-four (53.1%) of the original patients are still alive, now 
22; to 39 months posttransplant. Three are more than three years, nine 
are two and a half to three years, 17 are 24 to 30 months, and the other five are 
22; to 24 months postoperative (TABLE 1). 
The disparity in results with related, as opposed to nonrelated, donors2 is 
more evident than ever (TABLE 2). Only four (22.2%) of 18 patients who 
were provided with nonrelated kidneys are still alive, two having died during 
the second posttransplant year (FIGURE 12). By contrast, 30 (65.2%) of the 
46 patients who received kidneys from blood relatives survive to date; only 
one death has occurred after one year (See Case 2). 
Morbidity. Several late complications were reported in May of 1965 (TA- 
BLE 3). The most serious problem was delayed rejection, which usually seemed 
to follow a reduction in steroid dosage. Two of the nine patients previously 
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FIGURE 11. Liver from Case 2 (LD47). The majority of the hepatocytes are heavily 
laden with large fat droplets which appear black in the photomicrograph. Frozen section 
stained with oil red 0 x 150. 
TABLE 2 
EFFECT OF GENETIC RELATIONSHIP OF DONOR UPON 
ONE-YEAR SURVIVAL. 
Unrelated donors: 
All related donors: 
Parental  
Sibling 
Aunt, uncle o r  cousin 
Survival One Year Donors No. 
*One of these patients died af ter  13-1/2 months, and another af ter  23-1/2 
months. 
?One patient died after 22 months. 
18  
46 
20 
23 
3 
6*(33.3%) 
31  (67.4%) 
14 (70%) 
14?(60.9%) 
3 (100%) 
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FIGURE 12. Life survival curves of related and nonrelated cases treated a t  the Univer- 
sity of Colorado. The vertical arrows indicate the minimum follow-up for those patients 
still alive on February 16, 1966. The curve to the left of the arrows therefore represents 
survival data already achieved. The data to the right of the arrows are projected spce the 
post-transplantation survival time in currently living patients ranges from 222 to 39 
months. The 50 percent fractional survivorship is indicated by the centrally placed 
broken line (This graph is based upon life-survival computer analysis performed by 
Dr. M. R. Mickey of the University of California Center for the Health Sciences in Los 
Angeles) . 
TABLE 3 
LATE COMPLICATIONS 
Type of Complication Number by May 1965 New examples by February 1966 
Liver  injury 
Spontaneous bone fracture 
Ureteral  stenosis 
Chronic pyelonephritis 
Late rejection 
I I 
*Two of these patients were already dead in May, 1 9 6 5 . ~  A third (LD47) 
subsequently died (Case Report 2). 
?'One of these patients (LD36) died (see Case 1). 
reported had  died b y  M a y  of 1965; another  of th i s  group subsequently suc- 
cumbed. (Case 2). An  additional t w o  examples have  been seen i n  t h e  ensuing 
nine months. One of these pat ients  died of sepsis (Case 1); t h e  other  is still 
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alive and in good health, despite reduced function (BUN 40 mg%; Ccr 25- 
30 ml/ min) . 
Three patients in the presently reported series of chronic survivors were 
previously reported2 to have developed jaundice. One had already died by 
May of 1965. The two others had exhibited improvement in liver function 
after reduction of the daily azathioprine dose. One of these latter patients 
(Case 1) subsequently developed late rejection and died with a combination of 
advancing renal failure, liver malfunction and bacterial sepsis. The third pa- 
tient is still alive without jaundice, although there has been persistent hepatic 
dysfunction for 28 of the 31: months since homotransplantation. 
Two new observations of liver injury have been made. Patient LD37 re- 
ceived a renal transplant on October 18,1963. Jaundice was first noted in May 
of 1965. Hisazathioprine dose, which had been 175 mg or more since operation, 
was reduced to 75 mg/day. He is currently not jaundiced but does have eleva- 
tions in SGPT, SGOT and alkaline phosphatase and depressions of prothrom- 
bin time and BSP excretion. The other new example is documented in Case 2. 
There have been no new examples of the other major causes of late morbid- 
ity (TABLE 3). 
Renal function. Creatinine clearances, BUN'S and examinations of urine 
sediments are carried out on all patients a t  frequent intervals. In all but nine 
cases, PAH and inulin clearances, and concentration dilution capacity were 
measured on one or more occasions. Thirty-two of the 36 patients who were 
alive in May of 1965 have the same or improved function nine months later 
(TABLE 4). Of the four whose function deteriorated subsequent to May of 
1965, two have died. Three of these four patients had received kidneys from 
nonrelated donors. 
Pretransplant thymectomy. The four longest survivors in this series, now 34 
to 39 months posttransplantation, had thymectomy prior to the homografting 
procedure. The benignancy of their late course has been the subject of consid- 
erable interest. These four patients have now been off steroids from 18 months 
to almost three years without any evidence of homograft functional instabili- 
ty. The evidence for and against the concept that thymectomy may have been 
of benefit in these cases has recently been reviewed.' 
TABLE 4 
T R E N D  OF RENAL FUNCTION OF T H E  36 PATIENTS 
WHO WERE STILL ALIVE I N  MAY, 1965. 
Worse 4 * 
Same 3 1 
Better 1 
*Two of these patients (See Cases 1 & 2) are dead. The other two both re- 
ceived nonrelated kidneys. 
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The late failures reported in the present study, in which death was ulti- 
mately due to a combination of factors, probably represent a prototype that 
will be observed with increasing frequency. These two patients as well as a 
third2 who died after 1312 months had experienced late homograft rejection 
with consequent permanent impairment of homograft function. 
In each case, intensification of immunosuppressive therapy was necessary 
to maintain life-sustaining renal function. In each case, extra-renal complica- 
tions ensued to which the immunosuppression apparently contributed. The 
increased susceptibility to septic complications caused by bacteria or unusual 
opportunistic organisms, under these special circumstances, is not unexpected. 
Similarly, the pancreatitis which was seen in the two most recent deaths is 
not surprising, since this complication is often associated with either uremia4 
5 
or steroid therapy. 
The explanation for the late hepatic complications is less clear. In the 
present series, all three patients who died after one year had severe liver injury 
and two other long-term survivors also have chronic hepatic dysfunction. I t  is 
tempting to ascribe such complications to the hepatotoxicity of azathioprine, 
in view of the consistent parenchymal injury which this drug causes in the 
canine liver.6 However, a similar specific toxicity has not been well demon- 
strated in man.7 Furthermore, the clinical course and histopathologic studies 
in a t  least two of these five patients have been more consistent with the diag- 
nosis of viral hepatitis. I t  is probable that these complications are due to more 
than one etiologic factor. In this connection, the widespread fat emboli in one 
of the late homografts (Case 2) may have originated from a steroid-induced 
fatty liver, as has recently been reported by  ones.' 
With more complete information on the late morbidity and mortality after 
renal homotransplantation, both in this and in other s e r i e ~ , ~ - ' ~  i t  has become 
possible to speculate more authoritatively about the future of these patients. 
Up to the present time, the late death rate in related cases has conformed 
remarkably well to the optimistic pattern predicted in Barnes' life-survival 
curves17 which were prepared more than a year ago from the pooled National 
Academy of Sciences Registry. In the present series, the recipients of kidneys 
from blood relatives have fared extremely well, only one death having oc- 
curred from the seventh month onward; 65 per cent of the original group have 
now lived for 23 to 39 months. Furthermore, none of these survivors has had 
, 
any diminution in homograft function for the last year. The benefit to these 
patients has already been substantial and can be expected to continue for long 
intervals in spite of the histologic abnormalities present a t  two years in many 
of the homografts.18 
By contrast, it seems clear that the long-term prognosis of recipients of 
randomly selected unrelated homografts is extremely guarded. In  the present 
series, only six of 18 such patients lived for as long as one year. Two subse- 
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quently died during the second postoperative year, and homograft function in 
two of the remaining four has declined significantly in the last 12 months. 
Furthermore, the degree of histologic injury in the nonrelated homografts 
studied after one year has been severe.18 The observations emphasize that 
development of better immunosuppressive regimens and/or perfection of tis- 
sue typing techniques will be necessary before even moderately satisfactory 
long-term results can be expected within the unrelated donor-recipient human 
population. 
Sixty-four patients were treated, from November, 1962 to March, 1964, 
with renal homografts from living volunteer donors. After one year, 37 pa- 
tients were still alive. There have been three subsequent deaths after 131, 22 
and 23: months. The fatalities were due to a combination of reduced renal 
function and multiple extra-renal complications. The other 34 patients are still 
alive, now 22$ to 39 months postoperatively. 
The outlook, after homotransplantation of kidneys from related donors, re- 
mains favorable. Thirty of the original 46 patients are still alive; only one 
death has occurred after seven months. Moreover, the 30 survivors have all 
had stable renal function for the past year or longer. 
Both early and late results have been poor with nonrelated donor-recipient 
combinations. Only six of 18 such recipients lived for one year. Two have sub- 
sequently died during the second postoperative year, and two of the remaining 
four have had substantial declines in renal function during the latter interval. 
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